These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2415043)

  • 41. Signal sequences stop killer cells.
    Long EO
    Nature; 1998 Feb; 391(6669):740-1, 743. PubMed ID: 9486638
    [No Abstract]   [Full Text] [Related]  

  • 42. [The HLA histocompatibility system].
    Wadgymar A
    Rev Invest Clin; 1984; 36(3):287-92. PubMed ID: 6393263
    [No Abstract]   [Full Text] [Related]  

  • 43. NK cells and interferons.
    Paolini R; Bernardini G; Molfetta R; Santoni A
    Cytokine Growth Factor Rev; 2015 Apr; 26(2):113-20. PubMed ID: 25443799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Natural and antibody-dependent killer cells in the thymus.
    Zöller M; Andrighetto G; Heyman B
    Eur J Immunol; 1982 Nov; 12(11):914-21. PubMed ID: 6185347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HLA-G: a tolerance molecule from the major histocompatibility complex.
    Carosella ED; Rouas-Freiss N; Paul P; Dausset J
    Immunol Today; 1999 Feb; 20(2):60-2. PubMed ID: 10098322
    [No Abstract]   [Full Text] [Related]  

  • 46. Regulation of gene expression by interferons: control of H-2 promoter responses.
    Korber B; Mermod N; Hood L; Stroynowski I
    Science; 1988 Mar; 239(4845):1302-6. PubMed ID: 3125612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The different effect of alpha and gamma interferons and interleukin 2 on the expression of CD2, CD3, CD4 and CD8 antigens in comparison to histocompatibility antigens of human lymphocytes.
    Kotlán B; Böck G; Rajnavölgyi E; Benczur M; Mátyus L; Gyódi E; Huber C; Petrányi GG
    Immunol Lett; 1988 Aug; 18(4):259-68. PubMed ID: 2460402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MHC-unrestricted killing by T cells--multireceptor hypothesis.
    Hersey P; Bolhuis RL
    Immunol Today; 1990 Apr; 11(4):110-1. PubMed ID: 2340064
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of autologous tumor cells in preventing lymphokine-activated killer cell induction in vitro.
    Slovin SF; Maguire HC; Mastrangelo MJ
    Cancer; 1990 Dec; 66(12):2541-6. PubMed ID: 2123415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients].
    Sorokin AM; Koval'chuk LV; Tunkel' OI; Cheknev SB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):211-5. PubMed ID: 2437743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The importance of cytotoxic cellular immunity in the protection from cytomegalovirus infection.
    Quinnan GV; Rook AH
    Birth Defects Orig Artic Ser; 1984; 20(1):245-61. PubMed ID: 6329365
    [No Abstract]   [Full Text] [Related]  

  • 52. HLA related genetic control of natural killer activity and aflatoxin B1 suppression of lymphocytic blastogenesis.
    Wang CY; Yu XS; Hong JX; Lin TZ; Yang YQ
    Chin Med J (Engl); 1987 Jan; 100(1):29-33. PubMed ID: 3109821
    [No Abstract]   [Full Text] [Related]  

  • 53. Natural killer cells and interferon.
    Welsh RM
    Crit Rev Immunol; 1984; 5(1):55-93. PubMed ID: 6085941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of interferon-gamma during the mixed lymphocyte reaction.
    Toungouz M; Denys C; Andrien M; Dupont E
    Transplant Proc; 1996 Oct; 28(5):2911-2. PubMed ID: 8908120
    [No Abstract]   [Full Text] [Related]  

  • 55. Altered expression of nonclassical HLA class Ib antigens in human renal cell carcinoma and its association with impaired immune response.
    Bukur J; Malenica B; Huber C; Seliger B
    Hum Immunol; 2003 Nov; 64(11):1081-92. PubMed ID: 14602239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biologicals for cancer treatment: interferons.
    Oldham RK
    Hosp Pract (Off Ed); 1985 Dec; 20(12):71-4, 78-81, 85-6 passim. PubMed ID: 2415542
    [No Abstract]   [Full Text] [Related]  

  • 57. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular mechanisms in cell-mediated cytotoxicity.
    Moretta A
    Cell; 1997 Jul; 90(1):13-8. PubMed ID: 9230298
    [No Abstract]   [Full Text] [Related]  

  • 59. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
    Andrews PW; Trinchieri G; Perussia B; Baglioni C
    Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Class-I-restricted human cytotoxic T lymphocytes directed against minor transplantation antigens and their possible role in organ transplantation.
    Goulmy E
    Prog Allergy; 1985; 36():44-72. PubMed ID: 3881782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.